港股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

歐康維視生物-B

5.280

-0.060-1.12%

成交量：5.06萬

成交額：26.43萬

市值：43.03億

市盈率：-22.59

高：5.280

開：5.190

低：5.190

收：5.340

52周最高：9.560

52周最低：4.040

股本：8.15億

香港流通股本：8.15億

量比：1.73

換手率：0.01%

股息：- -

股息率：- -

每股收益(LYR):-0.234

淨資產收益率：-3.45%

總資產收益率：-1.93%

市淨率：1.02

市盈率(LYR):-22.59

市銷率: 3.94

資料載入中...

總覽公司新聞資訊公告

華泰製藥「救命藥」存致命缺陷，被踢出國家集採

歐康維視生物-B2026年8月股份變動月報表：股本保持穩定

中生製藥(01177.HK)GPC3 ADC臨床試驗申請獲FDA批准

阿斯达克财经

百奧賽圖與齊魯製藥達成全人納米抗體分子非排他授權合作，支持神經領域創新藥物開發

大行評級丨高盛：下調歌禮制藥目標價至13.86港元，維持「中性」評級

《大行》里昂：全球製藥供應鏈進入十年重整首選Thermo Fisher(TMO.US)、藥明康德(02359.HK)等平台龍頭

阿斯达克财经

歐康維視生物-B（01477）宣佈OT-211中國III期臨床試驗完成398名患者入組

歐康維視生物-B(01477)：OT-211 III期臨床試驗完成患者入組

歌禮制藥-B早盤升逾8% ASC30用於長期體重管理的全球III期臨床項目完成首例受試者給藥

港股異動 | 歌禮制藥-B(01672.HK)升逾5% ASC30用於長期體重管理的全球III期臨床項目完成首例受試者給藥

歌禮制藥－Ｂ(01672)股價上升5.031%，現價港幣$10.02

阿斯达克财经

歐康維視生物：地塞米松眼內懸濁液上市申請獲國家藥監局受理

諾華製藥（NVS）漲6% 在BTK抑制劑賽道迎來重要突破

諾華製藥(NVS)股票9月1日盤中上漲6.54%：真相來了

TradingKey中文

歐康維視生物-B：地塞米松眼用混懸注射液境內生產註冊申請獲國家藥監局受理

歐康維視生物-B(01477.HK)：境內生產的地塞米松眼用混懸注射液藥品註冊申請獲受理

歐康維視生物-B：國產地塞米松眼內懸濁液藥品註冊申請獲受理

歐康維視生物-B：地塞米松眼內懸濁液獲藥監局受理，列為化藥四類

南新制藥股民索賠案獲受理

諾華製藥(NVS.US)神經免疫管線「悲喜交加」：患者死亡致CAR-T臨床試驗暫停 MS口服藥後期試驗告捷

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.etasphere.com/hant/stock/01477/news?page=3"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"01477","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"01477\",,,,,undefined,":{"symbol":"01477","market":"HK","secType":"STK","nameCN":"歐康維視生物-B","latestPrice":5.28,"timestamp":1789523453269,"preClose":5.34,"halted":0,"volume":50623,"delay":0,"changeRate":-0.011235955056179702,"floatShares":815000000,"shares":815000000,"eps":-0.2337070013728182,"marketStatus":"交易中","change":-0.06,"latestTime":"09-16 09:56:54","open":5.19,"high":5.28,"low":5.19,"amount":264334,"amplitude":0.016854,"askPrice":5.31,"askSize":1500,"bidPrice":5.275,"bidSize":6000,"shortable":3,"etf":0,"ttmEps":-0.18005371653265345,"tradingStatus":2,"nextMarketStatus":{"tag":"午間休市","tradingStatus":4,"beginTime":1789531200000},"marketStatusCode":2,"adr":0,"listingDate":1594310400000,"exchange":"SEHK","adjPreClose":5.34,"openAndCloseTimeList":[[1789522200000,1789531200000],[1789534800000,1789545600000]],"volumeRatio":1.730691,"lotSize":500,"spreadScale":0,"tradeCurrency":"HKD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"01477\",,,,,undefined,":{"symbol":"01477","floatShares":815000000,"roa":"-1.93%","roe":"-3.45%","lyrEps":-0.233707,"volumeRatio":1.730691,"shares":815000000,"dividePrice":0,"high":5.28,"amplitude":0.016854,"preClose":5.34,"low":5.19,"week52Low":4.04,"pbRate":"1.02","psRate":"3.94","week52High":9.56,"institutionHeld":0,"latestPrice":5.28,"committee":0.6,"eps":-0.2337070013728182,"divideRate":0,"volume":50623,"delay":0,"ttmEps":-0.18005371653265345,"open":5.19,"prevYearClose":7.4,"prevWeekClose":5.33,"prevMonthClose":5.17,"prevQuarterClose":4.53,"fiveDayClose":5.365,"twentyDayClose":5.21,"sixtyDayClose":4.67},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/01477\",params:#limit:5,,,undefined,":[{"date":"2026-08-28","symbol":"01477","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1787880600000,"name":null,"time":"","dateTimestamp":1787846400000,"actualEps":null},{"date":"2026-03-26","symbol":"01477","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1774488600000,"name":null,"time":"","dateTimestamp":1774454400000,"actualEps":null},{"date":"2025-08-21","symbol":"01477","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1755739800000,"name":null,"time":"","dateTimestamp":1755705600000,"actualEps":null},{"date":"2025-03-31","symbol":"01477","type":"earning","reportTimeType":"post","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1743384600000,"name":null,"time":"盤後","dateTimestamp":1743350400000,"actualEps":null},{"date":"2024-08-12","symbol":"01477","type":"earning","reportTimeType":"post","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1723426200000,"name":null,"time":"盤後","dateTimestamp":1723392000000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"01477\",market:\"HK\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"01477\",market:\"HK\",delay:false,,,undefined,":{"strongBuy":0,"buy":0.5,"hold":0.5,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.5,"analysts":2,"updateTime":1752076800000},"@#url:\"https://hq.skytigris.cn/hkstock/value_analysis/stock/01477\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"01477","date":"2026-09-15","current":-29.324582,"percent":0.048361,"low":-38.626886,"twenty":-23.976138,"median":-14.83405,"eighty":-11.231051,"high":-7.188498,"avg":-16.990157,"sd":6.871173,"marketCap":4354142090},"quantilePoints":[{"date":"2021-09-17","current":-17.919626,"twenty":-5.642075,"median":-4.9626,"eighty":-4.482385,"marketCap":12781908945},{"date":"2021-09-24","current":-17.715417,"twenty":-5.722853,"median":-4.999957,"eighty":-4.484577,"marketCap":12642095005},{"date":"2021-09-30","current":-16.714815,"twenty":-5.814956,"median":-5.025941,"eighty":-4.492254,"marketCap":11967961356},{"date":"2021-10-08","current":-16.55485,"twenty":-5.903187,"median":-5.04,"eighty":-4.502208,"marketCap":11852884804},{"date":"2021-10-15","current":-16.561349,"twenty":-6.145246,"median":-5.063327,"eighty":-4.506525,"marketCap":11865671088},{"date":"2021-10-22","current":-15.911721,"twenty":-15.767892,"median":-5.080705,"eighty":-4.509981,"marketCap":11482082583},{"date":"2021-10-29","current":-15.027488,"twenty":-15.767892,"median":-5.10819,"eighty":-4.513635,"marketCap":10817195841},{"date":"2021-11-05","current":-13.832338,"twenty":-15.625971,"median":-5.127629,"eighty":-4.516896,"marketCap":9973301130},{"date":"2021-11-12","current":-14.09344,"twenty":-15.4579,"median":-5.185155,"eighty":-4.522269,"marketCap":10203454233},{"date":"2021-11-19","current":-15.734575,"twenty":-15.625971,"median":-5.208938,"eighty":-4.526693,"marketCap":11375493993},{"date":"2021-11-26","current":-16.069929,"twenty":-15.785538,"median":-5.22622,"eighty":-4.534134,"marketCap":11621660719},{"date":"2021-12-03","current":-14.734877,"twenty":-15.712796,"median":-5.240678,"eighty":-4.544256,"marketCap":10675862244},{"date":"2021-12-10","current":-14.674057,"twenty":-15.66613,"median":-5.289338,"eighty":-4.55664,"marketCap":10649949957},{"date":"2021-12-17","current":-15.380904,"twenty":-15.66613,"median":-5.296159,"eighty":-4.56848,"marketCap":11155239553},{"date":"2021-12-24","current":-15.999084,"twenty":-15.712796,"median":-5.33531,"eighty":-4.574927,"marketCap":11614666108},{"date":"2021-12-31","current":-16.037673,"twenty":-15.802526,"median":-5.370316,"eighty":-4.577767,"marketCap":11668005562},{"date":"2022-01-07","current":-15.362852,"twenty":-15.976924,"median":-15.708528,"eighty":-15.343793,"marketCap":11134611022},{"date":"2022-01-14","current":-14.760347,"twenty":-15.869673,"median":-15.399648,"eighty":-15.183935,"marketCap":10721230254},{"date":"2022-01-21","current":-13.499414,"twenty":-15.821688,"median":-15.267709,"eighty":-14.05708,"marketCap":9827794399},{"date":"2022-01-28","current":-10.540695,"twenty":-15.752863,"median":-15.077925,"eighty":-13.295024,"marketCap":7654211649},{"date":"2022-02-04","current":-10.251902,"twenty":-15.708528,"median":-14.885331,"eighty":-11.992853,"marketCap":7440853833},{"date":"2022-02-11","current":-8.966084,"twenty":-15.436443,"median":-13.94129,"eighty":-10.461655,"marketCap":6520748251},{"date":"2022-02-18","current":-8.75805,"twenty":-15.362852,"median":-13.57487,"eighty":-9.154579,"marketCap":6400734480},{"date":"2022-02-25","current":-8.217781,"twenty":-15.315206,"median":-11.992853,"eighty":-8.966084,"marketCap":6020690870},{"date":"2022-03-04","current":-7.959917,"twenty":-15.267709,"median":-10.78446,"eighty":-8.742668,"marketCap":5834002781},{"date":"2022-03-11","current":-7.953732,"twenty":-15.209535,"median":-10.251902,"eighty":-8.217781,"marketCap":5820667917},{"date":"2022-03-18","current":-9.00092,"twenty":-15.145534,"median":-9.281763,"eighty":-8.15549,"marketCap":6560752842},{"date":"2022-03-25","current":-20.03898,"twenty":-15.145534,"median":-9.247054,"eighty":-8.198692,"marketCap":6407401911},{"date":"2022-04-01","current":-20.410894,"twenty":-15.362852,"median":-9.707225,"eighty":-8.217781,"marketCap":6534083115},{"date":"2022-04-08","current":-19.444406,"twenty":-15.820527,"median":-10.356779,"eighty":-8.367592,"marketCap":6227381254},{"date":"2022-04-14","current":-19.163827,"twenty":-16.133525,"median":-10.78446,"eighty":-8.528306,"marketCap":6127369778},{"date":"2022-04-22","current":-18.763843,"twenty":-18.617395,"median":-11.77794,"eighty":-8.662398,"marketCap":5887342235},{"date":"2022-04-29","current":-20.431438,"twenty":-18.829722,"median":-13.499414,"eighty":-8.741232,"marketCap":6307390435},{"date":"2022-05-06","current":-21.560836,"twenty":-19.323222,"median":-13.869952,"eighty":-8.744113,"marketCap":6600757432},{"date":"2022-05-13","current":-21.776236,"twenty":-20.03898,"median":-14.134274,"eighty":-8.749895,"marketCap":6547417978},{"date":"2022-05-20","current":-23.53057,"twenty":-20.555483,"median":-15.077925,"eighty":-8.75805,"marketCap":7174156563},{"date":"2022-05-27","current":-25.827306,"twenty":-20.841108,"median":-15.267709,"eighty":-8.767241,"marketCap":7867569465},{"date":"2022-06-02","current":-23.164027,"twenty":-21.040193,"median":-15.362852,"eighty":-8.808698,"marketCap":7094147382},{"date":"2022-06-10","current":-25.205762,"twenty":-21.427717,"median":-15.763947,"eighty":-8.863855,"marketCap":7667546512},{"date":"2022-06-17","current":-22.600375,"twenty":-22.621643,"median":-15.936425,"eighty":-8.947878,"marketCap":6867454702},{"date":"2022-06-24","current":-25.789016,"twenty":-23.073136,"median":-17.425376,"eighty":-8.980466,"marketCap":7867569465},{"date":"2022-06-30","current":-30.785831,"twenty":-23.383434,"median":-18.611556,"eighty":-8.994177,"marketCap":9375799960},{"date":"2022-07-08","current":-32.068453,"twenty":-23.73257,"median":-18.786504,"eighty":-9.043272,"marketCap":9776475172},{"date":"2022-07-15","current":-28.00403,"twenty":-24.034291,"median":-19.000756,"eighty":-9.085113,"marketCap":8458263105},{"date":"2022-07-22","current":-28.203998,"twenty":-24.603827,"median":-19.352501,"eighty":-9.130421,"marketCap":8524249533},{"date":"2022-07-29","current":-25.648963,"twenty":-25.491945,"median":-19.780424,"eighty":-9.18781,"marketCap":7761483092},{"date":"2022-08-05","current":-25.734637,"twenty":-25.491945,"median":-20.431438,"eighty":-9.232218,"marketCap":7767573455},{"date":"2022-08-12","current":-24.988206,"twenty":-25.59293,"median":-20.610854,"eighty":-9.247341,"marketCap":7552554120},{"date":"2022-08-19","current":-25.375593,"twenty":-25.502397,"median":-20.800689,"eighty":-9.288896,"marketCap":7592870246},{"date":"2022-08-26","current":-20.126435,"twenty":-25.755289,"median":-20.89267,"eighty":-9.785376,"marketCap":8802354002},{"date":"2022-09-02","current":-19.952253,"twenty":-25.683233,"median":-20.944232,"eighty":-10.190332,"marketCap":8694844334},{"date":"2022-09-09","current":-16.282831,"twenty":-25.59293,"median":-20.75148,"eighty":-10.377754,"marketCap":7068760618},{"date":"2022-09-16","current":-15.622331,"twenty":-25.520123,"median":-20.610854,"eighty":-10.493271,"marketCap":6719354200},{"date":"2022-09-23","current":-13.921158,"twenty":-25.459978,"median":-20.431438,"eighty":-10.735707,"marketCap":5872715570},{"date":"2022-09-30","current":-16.215684,"twenty":-25.433681,"median":-20.159202,"eighty":-11.242146,"marketCap":6853741284},{"date":"2022-10-07","current":-17.965466,"twenty":-25.403051,"median":-19.995616,"eighty":-11.648992,"marketCap":7592870246},{"date":"2022-10-14","current":-17.193919,"twenty":-25.347638,"median":-19.444406,"eighty":-12.19197,"marketCap":7189708994},{"date":"2022-10-21","current":-15.370891,"twenty":-25.229807,"median":-19.184967,"eighty":-13.090633,"marketCap":6383386490},{"date":"2022-10-28","current":-12.350225,"twenty":-25.203055,"median":-18.817778,"eighty":-13.029636,"marketCap":5120147900},{"date":"2022-11-04","current":-14.77289,"twenty":-25.175764,"median":-18.702298,"eighty":-12.639818,"marketCap":6184131854},{"date":"2022-11-11","current":-14.897053,"twenty":-25.085564,"median":-18.573447,"eighty":-13.029636,"marketCap":6291681973},{"date":"2022-11-18","current":-14.037952,"twenty":-24.959422,"median":-18.044287,"eighty":-13.255426,"marketCap":5908534673},{"date":"2022-11-25","current":-12.476013,"twenty":-24.831652,"median":-17.193919,"eighty":-12.829263,"marketCap":5209458898},{"date":"2022-12-02","current":-13.119273,"twenty":-24.772935,"median":-17.025185,"eighty":-12.587106,"marketCap":5572601763},{"date":"2022-12-09","current":-16.03205,"twenty":-24.739495,"median":-16.688733,"eighty":-12.737959,"marketCap":6873100119},{"date":"2022-12-16","current":-14.179,"twenty":-24.68646,"median":-16.469524,"eighty":-12.793318,"marketCap":6064500105},{"date":"2022-12-23","current":-14.599824,"twenty":-24.480721,"median":-16.277304,"eighty":-12.829263,"marketCap":6246435108},{"date":"2022-12-30","current":-15.264843,"twenty":-24.465983,"median":-16.259049,"eighty":-12.900795,"marketCap":6610305114},{"date":"2023-01-06","current":-16.215203,"twenty":-24.397931,"median":-16.224073,"eighty":-12.962375,"marketCap":7093988988},{"date":"2023-01-13","current":-15.84912,"twenty":-24.355307,"median":-16.215684,"eighty":-12.988076,"marketCap":7066439516},{"date":"2023-01-20","current":-15.799324,"twenty":-24.33352,"median":-16.158901,"eighty":-13.014011,"marketCap":6983791101},{"date":"2023-01-27","current":-15.515689,"twenty":-24.319232,"median":-16.070136,"eighty":-13.031059,"marketCap":6859818478},{"date":"2023-02-03","current":-19.589153,"twenty":-24.287259,"median":-16.215203,"eighty":-13.119273,"marketCap":8705633088},{"date":"2023-02-10","current":-17.212944,"twenty":-24.279401,"median":-16.241102,"eighty":-13.194429,"marketCap":7603654216},{"date":"2023-02-17","current":-16.495851,"twenty":-23.865645,"median":-16.277304,"eighty":-13.478009,"marketCap":7217961611},{"date":"2023-02-24","current":-16.062616,"twenty":-23.808592,"median":-16.355831,"eighty":-13.499414,"marketCap":6942466893},{"date":"2023-03-03","current":-15.611378,"twenty":-23.786071,"median":-16.268356,"eighty":-13.504736,"marketCap":6790944798},{"date":"2023-03-09","current":-14.467351,"twenty":-14.467351,"median":-14.467351,"eighty":-14.467351,"marketCap":6246842730},{"date":"2023-03-17","current":-14.186534,"twenty":-17.810176,"median":-13.188769,"eighty":-4.7618,"marketCap":6184856419},{"date":"2023-03-24","current":-13.713132,"twenty":-17.78787,"median":-13.366045,"eighty":-4.77053,"marketCap":6047109060},{"date":"2023-03-31","current":-15.00298,"twenty":-17.748266,"median":-13.502075,"eighty":-4.773263,"marketCap":6901142685},{"date":"2023-04-06","current":-13.978857,"twenty":-17.727555,"median":-13.553878,"eighty":-4.773898,"marketCap":6425914297},{"date":"2023-04-14","current":-14.653593,"twenty":-17.715417,"median":-13.650327,"eighty":-4.774125,"marketCap":6742733223},{"date":"2023-04-21","current":-13.537962,"twenty":-17.680082,"median":-13.628648,"eighty":-4.776621,"marketCap":6226180626},{"date":"2023-04-28","current":-13.307585,"twenty":-17.604824,"median":-13.606969,"eighty":-4.779009,"marketCap":6074658531},{"date":"2023-05-05","current":-12.186181,"twenty":-17.504064,"median":-13.537962,"eighty":-4.783959,"marketCap":5571880671},{"date":"2023-05-12","current":-12.374672,"twenty":-17.460652,"median":-13.510651,"eighty":-4.787325,"marketCap":5619102626},{"date":"2023-05-19","current":-12.150758,"twenty":-17.434791,"median":-13.499414,"eighty":-4.788245,"marketCap":5439842911},{"date":"2023-05-25","current":-11.999934,"twenty":-17.408556,"median":-13.458465,"eighty":-4.788511,"marketCap":5350213053},{"date":"2023-06-02","current":-10.861514,"twenty":-17.321947,"median":-13.307585,"eighty":-4.789427,"marketCap":4826223115},{"date":"2023-06-09","current":-11.083745,"twenty":-17.205334,"median":-13.188769,"eighty":-4.792014,"marketCap":4917864313},{"date":"2023-06-16","current":-13.139255,"twenty":-17.190746,"median":-13.139255,"eighty":-4.794649,"marketCap":5801974752},{"date":"2023-06-23","current":-12.424925,"twenty":-17.175611,"median":-13.139255,"eighty":-4.796062,"marketCap":5456619112},{"date":"2023-06-30","current":-12.093947,"twenty":-17.12621,"median":-13.07829,"eighty":-4.799737,"marketCap":5263219953},{"date":"2023-07-07","current":-13.389773,"twenty":-17.102509,"median":-13.118476,"eighty":-4.803974,"marketCap":5815788977},{"date":"2023-07-14","current":-13.753363,"twenty":-17.036899,"median":-13.139255,"eighty":-4.807787,"marketCap":6057537925},{"date":"2023-07-20","current":-14.430539,"twenty":-16.996838,"median":-13.18311,"eighty":-4.811222,"marketCap":6278565535},{"date":"2023-07-28","current":-15.598894,"twenty":-16.989121,"median":-13.212733,"eighty":-4.814083,"marketCap":6831134559},{"date":"2023-08-04","current":-15.14786,"twenty":-16.970977,"median":-13.350645,"eighty":-4.831333,"marketCap":6644642513},{"date":"2023-08-11","current":-14.647957,"twenty":-16.946672,"median":-13.386742,"eighty":-4.861783,"marketCap":6389079340},{"date":"2023-08-18","current":-13.972047,"twenty":-16.90474,"median":-13.390295,"eighty":-4.882703,"marketCap":6050630812},{"date":"2023-08-25","current":-13.10246,"twenty":-16.880543,"median":-13.390817,"eighty":-4.890058,"marketCap":5898674331},{"date":"2023-09-01","current":-12.620471,"twenty":-16.864109,"median":-13.387943,"eighty":-4.895187,"marketCap":5705275172},{"date":"2023-09-08","current":-11.904998,"twenty":-16.824648,"median":-13.350645,"eighty":-4.903128,"marketCap":5318476856},{"date":"2023-09-15","current":-11.230403,"twenty":-16.802097,"median":-13.265027,"eighty":-4.903271,"marketCap":5056006569},{"date":"2023-09-22","current":-11.341358,"twenty":-16.779449,"median":-13.194429,"eighty":-4.90451,"marketCap":5083635020},{"date":"2023-09-29","current":-11.76805,"twenty":-16.776159,"median":-13.160583,"eighty":-4.909484,"marketCap":5283941292},{"date":"2023-10-06","current":-11.499865,"twenty":-16.767615,"median":-13.118875,"eighty":-4.915814,"marketCap":5161051759},{"date":"2023-10-13","current":-12.149198,"twenty":-16.749672,"median":-13.038103,"eighty":-4.938988,"marketCap":5444322338},{"date":"2023-10-20","current":-11.195128,"twenty":-16.714815,"median":-12.989669,"eighty":-4.941026,"marketCap":5009052912},{"date":"2023-10-27","current":-11.771516,"twenty":-16.714587,"median":-12.979403,"eighty":-4.941428,"marketCap":5264687337},{"date":"2023-11-03","current":-11.678713,"twenty":-16.693892,"median":-12.901146,"eighty":-4.949859,"marketCap":5237051183},{"date":"2023-11-10","current":-11.295891,"twenty":-16.592188,"median":-12.855669,"eighty":-4.960468,"marketCap":5064325220},{"date":"2023-11-17","current":-11.301834,"twenty":-16.56269,"median":-12.805419,"eighty":-4.970911,"marketCap":5112688490},{"date":"2023-11-24","current":-10.921738,"twenty":-16.55615,"median":-12.78783,"eighty":-4.994563,"marketCap":4981416758},{"date":"2023-12-01","current":-10.363731,"twenty":-16.545792,"median":-12.724876,"eighty":-5.018089,"marketCap":4746509449},{"date":"2023-12-08","current":-10.345202,"twenty":-16.543,"median":-12.620259,"eighty":-5.024614,"marketCap":4718873295},{"date":"2023-12-15","current":-10.390396,"twenty":-16.509698,"median":-12.606339,"eighty":-5.025775,"marketCap":4766857065},{"date":"2023-12-22","current":-9.98884,"twenty":-16.496962,"median":-12.569609,"eighty":-5.031334,"marketCap":4579572055},{"date":"2023-12-29","current":-10.00978,"twenty":-16.487733,"median":-12.552663,"eighty":-5.03457,"marketCap":4613641198},{"date":"2024-01-05","current":-9.655373,"twenty":-16.475036,"median":-12.52701,"eighty":-5.038441,"marketCap":4418904640},{"date":"2024-01-12","current":-9.39352,"twenty":-16.471745,"median":-12.483453,"eighty":-5.04476,"marketCap":4301352696},{"date":"2024-01-19","current":-8.494772,"twenty":-16.461062,"median":-12.440637,"eighty":-5.057375,"marketCap":3884467160},{"date":"2024-01-26","current":-7.918821,"twenty":-16.43588,"median":-12.425318,"eighty":-5.07372,"marketCap":3607005220},{"date":"2024-02-02","current":-7.288517,"twenty":-16.40444,"median":-12.417213,"eighty":-5.076625,"marketCap":3315670183},{"date":"2024-02-09","current":-7.525916,"twenty":-16.302071,"median":-12.387736,"eighty":-5.081389,"marketCap":3440528056},{"date":"2024-02-16","current":-7.630479,"twenty":-16.287641,"median":-12.374672,"eighty":-5.08344,"marketCap":3489083895},{"date":"2024-02-23","current":-7.869172,"twenty":-16.278409,"median":-12.342212,"eighty":-5.096914,"marketCap":3579259026},{"date":"2024-03-01","current":-7.788063,"twenty":-16.270146,"median":-12.291624,"eighty":-5.105169,"marketCap":3544576283},{"date":"2024-03-08","current":-7.830304,"twenty":-16.259058,"median":-12.247943,"eighty":-5.109244,"marketCap":3565385929},{"date":"2024-03-15","current":-9.316254,"twenty":-16.25114,"median":-12.197696,"eighty":-5.122063,"marketCap":4238231133},{"date":"2024-03-22","current":-9.202691,"twenty":-16.235918,"median":-12.180287,"eighty":-5.127122,"marketCap":4182738745},{"date":"2024-03-28","current":-9.752114,"twenty":-16.222395,"median":-12.149978,"eighty":-5.150646,"marketCap":4009325033},{"date":"2024-04-05","current":-9.451256,"twenty":-16.215588,"median":-12.093947,"eighty":-5.168328,"marketCap":3884467160},{"date":"2024-04-12","current":-9.935055,"twenty":-16.214165,"median":-12.063192,"eighty":-5.180253,"marketCap":4085627066},{"date":"2024-04-19","current":-10.027955,"twenty":-16.206183,"median":-12.045317,"eighty":-5.190965,"marketCap":4120309809},{"date":"2024-04-26","current":-10.936189,"twenty":-16.173218,"median":-12.018272,"eighty":-5.195186,"marketCap":4487946879},{"date":"2024-05-03","current":-12.093948,"twenty":-16.102599,"median":-12.034964,"eighty":-5.205405,"marketCap":4959632177},{"date":"2024-05-10","current":-11.457819,"twenty":-16.071484,"median":-12.04427,"eighty":-5.208938,"marketCap":4709916431},{"date":"2024-05-17","current":-11.728152,"twenty":-16.07024,"median":-12.010885,"eighty":-5.21252,"marketCap":4813964659},{"date":"2024-05-24","current":-11.82275,"twenty":-16.064079,"median":-11.998571,"eighty":-5.221182,"marketCap":4841710853},{"date":"2024-05-31","current":-11.472313,"twenty":-16.044366,"median":-11.965119,"eighty":-5.228078,"marketCap":4702979883},{"date":"2024-06-07","current":-11.469617,"twenty":-16.038669,"median":-11.895454,"eighty":-5.231226,"marketCap":4696043334},{"date":"2024-06-14","current":-11.463178,"twenty":-16.037958,"median":-11.88657,"eighty":-5.233283,"marketCap":4689106786},{"date":"2024-06-21","current":-11.623169,"twenty":-16.037649,"median":-11.850983,"eighty":-5.238141,"marketCap":4744599174},{"date":"2024-06-28","current":-11.644993,"twenty":-16.037436,"median":-11.835278,"eighty":-5.24241,"marketCap":4751535722},{"date":"2024-07-05","current":-11.392467,"twenty":-16.035202,"median":-11.822711,"eighty":-5.261138,"marketCap":4647487495},{"date":"2024-07-12","current":-11.783247,"twenty":-16.022334,"median":-11.813224,"eighty":-5.28897,"marketCap":4813964659},{"date":"2024-07-19","current":-11.969789,"twenty":-16.00429,"median":-11.819336,"eighty":-5.29261,"marketCap":4890266692},{"date":"2024-07-26","current":-11.418017,"twenty":-15.991674,"median":-11.80343,"eighty":-5.29532,"marketCap":4682170237},{"date":"2024-08-02","current":-11.81396,"twenty":-15.972998,"median":-11.80273,"eighty":-5.298835,"marketCap":4841710853},{"date":"2024-08-09","current":-12.273772,"twenty":-15.951565,"median":-11.813224,"eighty":-5.312829,"marketCap":5063680405},{"date":"2024-08-16","current":-12.994451,"twenty":-15.928798,"median":-11.819336,"eighty":-5.331528,"marketCap":4557312364},{"date":"2024-08-23","current":-10.495101,"twenty":-15.915103,"median":-11.81396,"eighty":-5.3394,"marketCap":3696316872},{"date":"2024-08-30","current":-10.868577,"twenty":-15.907617,"median":-11.80273,"eighty":-5.346748,"marketCap":3853551180},{"date":"2024-09-06","current":-9.30501,"twenty":-15.884786,"median":-11.794044,"eighty":-5.358175,"marketCap":3300763114},{"date":"2024-09-13","current":-8.249993,"twenty":-15.855511,"median":-11.787115,"eighty":-5.369549,"marketCap":2918856638},{"date":"2024-09-20","current":-9.043888,"twenty":-15.84433,"median":-11.778296,"eighty":-5.374828,"marketCap":3218926012},{"date":"2024-09-27","current":-10.798914,"twenty":-15.82404,"median":-11.76805,"eighty":-5.379217,"marketCap":3866695339},{"date":"2024-10-04","current":-13.045185,"twenty":-15.819514,"median":-11.773346,"eighty":-5.385999,"marketCap":4649786317},{"date":"2024-10-10","current":-12.432139,"twenty":-15.819396,"median":-11.785708,"eighty":-5.391573,"marketCap":4404343051},{"date":"2024-10-18","current":-12.524383,"twenty":-15.803332,"median":-11.784477,"eighty":-5.420261,"marketCap":4412120868},{"date":"2024-10-25","current":-13.529553,"twenty":-15.778984,"median":-11.791541,"eighty":-5.433408,"marketCap":4765922421},{"date":"2024-11-01","current":-12.777047,"twenty":-15.767561,"median":-11.801918,"eighty":-5.437884,"marketCap":4503878577},{"date":"2024-11-08","current":-12.777615,"twenty":-15.746144,"median":-11.812828,"eighty":-5.441041,"marketCap":4469951926},{"date":"2024-11-15","current":-12.026026,"twenty":-15.735897,"median":-11.81498,"eighty":-5.46553,"marketCap":4175229821},{"date":"2024-11-22","current":-12.221559,"twenty":-15.733887,"median":-11.82275,"eighty":-5.471679,"marketCap":4240673817},{"date":"2024-11-29","current":-12.201205,"twenty":-15.732171,"median":-11.842765,"eighty":-5.492718,"marketCap":4231202782},{"date":"2024-12-06","current":-11.804661,"twenty":-15.724824,"median":-11.847501,"eighty":-5.519701,"marketCap":4084045070},{"date":"2024-12-13","current":-11.413706,"twenty":-15.715253,"median":-11.846732,"eighty":-5.542046,"marketCap":3945187537},{"date":"2024-12-20","current":-10.621302,"twenty":-15.709481,"median":-11.830988,"eighty":-5.572181,"marketCap":3651136292},{"date":"2024-12-27","current":-10.558209,"twenty":-15.707874,"median":-11.822711,"eighty":-5.581194,"marketCap":3626632022},{"date":"2025-01-03","current":-10.272109,"twenty":-15.701541,"median":-11.81498,"eighty":-5.586972,"marketCap":3531814355},{"date":"2025-01-10","current":-9.144324,"twenty":-15.673129,"median":-11.812828,"eighty":-5.598187,"marketCap":3132140213},{"date":"2025-01-17","current":-9.089363,"twenty":-15.642537,"median":-11.80273,"eighty":-5.61281,"marketCap":3115826983},{"date":"2025-01-24","current":-9.978603,"twenty":-15.631733,"median":-11.794044,"eighty":-5.618275,"marketCap":3442091589},{"date":"2025-01-28","current":-10.213588,"twenty":-15.630903,"median":-11.791541,"eighty":-5.618594,"marketCap":3539970970},{"date":"2025-02-07","current":-9.817469,"twenty":-15.625428,"median":-11.784477,"eighty":-5.631477,"marketCap":3384995283},{"date":"2025-02-14","current":-9.945385,"twenty":-15.620823,"median":-11.771516,"eighty":-5.641186,"marketCap":3420910893},{"date":"2025-02-21","current":-10.837702,"twenty":-15.614754,"median":-11.755703,"eighty":-5.646278,"marketCap":3748285864},{"date":"2025-02-28","current":-10.731401,"twenty":-15.607456,"median":-11.744537,"eighty":-5.662074,"marketCap":3699288663},{"date":"2025-03-07","current":-11.321783,"twenty":-15.601273,"median":-11.735201,"eighty":-5.684454,"marketCap":3918472867},{"date":"2025-03-14","current":-11.341243,"twenty":-15.59717,"median":-11.728152,"eighty":-5.706183,"marketCap":3926636352},{"date":"2025-03-21","current":-11.888217,"twenty":-15.595245,"median":-11.733767,"eighty":-5.731296,"marketCap":4114396510},{"date":"2025-03-28","current":-11.770508,"twenty":-15.592001,"median":-11.733691,"eighty":-5.75056,"marketCap":4065415599},{"date":"2025-04-03","current":-14.751549,"twenty":-15.589005,"median":-11.736558,"eighty":-5.756839,"marketCap":4236848787},{"date":"2025-04-11","current":-13.660953,"twenty":-15.572459,"median":-11.745588,"eighty":-5.771274,"marketCap":3888499296},{"date":"2025-04-17","current":-13.633486,"twenty":-15.544381,"median":-11.755703,"eighty":-5.792587,"marketCap":3885823326},{"date":"2025-04-25","current":-15.746615,"twenty":-15.587239,"median":-11.769279,"eighty":-5.799042,"marketCap":4496801837},{"date":"2025-05-02","current":-15.485488,"twenty":-15.55768,"median":-11.772431,"eighty":-5.805536,"marketCap":4431630796},{"date":"2025-05-09","current":-14.947815,"twenty":-15.543609,"median":-11.784477,"eighty":-5.833423,"marketCap":4307789904},{"date":"2025-05-16","current":-15.022877,"twenty":-15.528108,"median":-11.791541,"eighty":-5.852828,"marketCap":4364792795},{"date":"2025-05-23","current":-20.135572,"twenty":-15.592001,"median":-11.800885,"eighty":-5.855951,"marketCap":5867750450},{"date":"2025-05-30","current":-21.298662,"twenty":-15.607456,"median":-11.80343,"eighty":-5.876258,"marketCap":6233976207},{"date":"2025-06-06","current":-21.244462,"twenty":-15.630903,"median":-11.813026,"eighty":-5.910295,"marketCap":6233976207},{"date":"2025-06-13","current":-27.307472,"twenty":-15.707548,"median":-11.816,"eighty":-5.952352,"marketCap":8016274887},{"date":"2025-06-20","current":-29.166656,"twenty":-15.732557,"median":-11.826869,"eighty":-6.048198,"marketCap":8545267647},{"date":"2025-06-27","current":-28.919005,"twenty":-15.75436,"median":-11.845963,"eighty":-6.145246,"marketCap":8496437546},{"date":"2025-07-04","current":-25.178295,"twenty":-15.789154,"median":-11.847833,"eighty":-6.263496,"marketCap":7397760277},{"date":"2025-07-11","current":-24.732328,"twenty":-15.85125,"median":-11.8842,"eighty":-7.268513,"marketCap":7259408324},{"date":"2025-07-18","current":-27.665324,"twenty":-15.941472,"median":-11.888217,"eighty":-7.268513,"marketCap":8113935089},{"date":"2025-07-25","current":-25.933847,"twenty":-16.033101,"median":-11.88894,"eighty":-7.268513,"marketCap":7633772431},{"date":"2025-08-01","current":-26.206368,"twenty":-16.044366,"median":-11.904998,"eighty":-7.268513,"marketCap":7666325831},{"date":"2025-08-08","current":-29.332286,"twenty":-16.194701,"median":-11.918048,"eighty":-7.268513,"marketCap":8602236097},{"date":"2025-08-15","current":-30.349029,"twenty":-16.25114,"median":-11.918048,"eighty":-7.268513,"marketCap":8887078352},{"date":"2025-08-22","current":-34.031861,"twenty":-16.331271,"median":-11.918048,"eighty":-7.268513,"marketCap":9229914978},{"date":"2025-08-29","current":-26.659291,"twenty":-16.479616,"median":-11.969789,"eighty":-7.360324,"marketCap":7264888909},{"date":"2025-09-05","current":-31.447836,"twenty":-16.55615,"median":-12.003641,"eighty":-7.539996,"marketCap":8561316897},{"date":"2025-09-12","current":-29.448737,"twenty":-16.721786,"median":-12.025658,"eighty":-7.617894,"marketCap":8031516777},{"date":"2025-09-19","current":-26.507726,"twenty":-16.811927,"median":-12.053683,"eighty":-7.703553,"marketCap":7224288188},{"date":"2025-09-26","current":-24.446948,"twenty":-16.933815,"median":-12.093948,"eighty":-7.778,"marketCap":6645366674},{"date":"2025-10-03","current":-26.184232,"twenty":-16.998426,"median":-12.134967,"eighty":-7.824436,"marketCap":7134596122},{"date":"2025-10-10","current":-24.484269,"twenty":-17.197724,"median":-12.174393,"eighty":-7.918017,"marketCap":6661674322},{"date":"2025-10-17","current":-23.003751,"twenty":-17.504064,"median":-12.214069,"eighty":-7.97714,"marketCap":6253983115},{"date":"2025-10-24","current":-25.034094,"twenty":-17.781326,"median":-12.251704,"eighty":-8.133495,"marketCap":6808443156},{"date":"2025-10-31","current":-24.99681,"twenty":-17.928794,"median":-12.275081,"eighty":-8.218372,"marketCap":6808443156},{"date":"2025-11-07","current":-25.012434,"twenty":-18.096512,"median":-12.303472,"eighty":-8.404866,"marketCap":6808443156},{"date":"2025-11-14","current":-25.389814,"twenty":-18.175981,"median":-12.352134,"eighty":-8.668101,"marketCap":6930750519},{"date":"2025-11-21","current":-23.3994,"twenty":-18.586246,"median":-12.402617,"eighty":-8.765403,"marketCap":6384444301},{"date":"2025-11-28","current":-24.41643,"twenty":-18.768375,"median":-12.425757,"eighty":-8.913659,"marketCap":6686135794},{"date":"2025-12-05","current":-24.671774,"twenty":-18.919649,"median":-12.470603,"eighty":-8.976873,"marketCap":6767674036},{"date":"2025-12-12","current":-24.477873,"twenty":-19.235387,"median":-12.502284,"eighty":-9.063021,"marketCap":6726904915},{"date":"2025-12-19","current":-24.183517,"twenty":-19.628733,"median":-12.583124,"eighty":-9.101339,"marketCap":6661674322},{"date":"2025-12-24","current":-23.173037,"twenty":-19.956971,"median":-12.606339,"eighty":-9.153864,"marketCap":6392598125},{"date":"2026-01-02","current":-22.19156,"twenty":-20.158131,"median":-12.667798,"eighty":-9.243719,"marketCap":6156137225},{"date":"2026-01-09","current":-23.367871,"twenty":-20.59978,"median":-12.758934,"eighty":-9.311756,"marketCap":6498597839},{"date":"2026-01-16","current":-21.860164,"twenty":-20.913856,"median":-12.845486,"eighty":-9.34493,"marketCap":6099060456},{"date":"2026-01-23","current":-21.237593,"twenty":-21.04457,"median":-12.979403,"eighty":-9.423101,"marketCap":5919676325},{"date":"2026-01-30","current":-21.519504,"twenty":-21.122046,"median":-13.011939,"eighty":-9.468628,"marketCap":6025676039},{"date":"2026-02-06","current":-20.303216,"twenty":-21.122046,"median":-13.10007,"eighty":-9.542179,"marketCap":5699523073},{"date":"2026-02-13","current":-20.216143,"twenty":-21.108339,"median":-13.194429,"eighty":-9.635808,"marketCap":5707676898},{"date":"2026-02-20","current":-21.286491,"twenty":-21.207823,"median":-13.264774,"eighty":-9.660283,"marketCap":6001214567},{"date":"2026-02-27","current":-21.57052,"twenty":-21.239268,"median":-13.386742,"eighty":-9.69819,"marketCap":6147983401},{"date":"2026-03-06","current":-19.986549,"twenty":-21.239268,"median":-13.397476,"eighty":-9.854441,"marketCap":5650600129},{"date":"2026-03-13","current":-20.21071,"twenty":-21.239268,"median":-13.478009,"eighty":-9.906487,"marketCap":5740292194},{"date":"2026-03-20","current":-19.999355,"twenty":-21.239268,"median":-13.514524,"eighty":-9.940684,"marketCap":5658753953},{"date":"2026-03-27","current":-33.235486,"twenty":-21.242622,"median":-13.606969,"eighty":-9.997216,"marketCap":5976753094},{"date":"2026-04-02","current":-38.626886,"twenty":-21.356127,"median":-13.660953,"eighty":-10.062622,"marketCap":6979673463},{"date":"2026-04-10","current":-36.271391,"twenty":-21.439965,"median":-13.68927,"eighty":-10.103164,"marketCap":6604597553},{"date":"2026-04-17","current":-36.972339,"twenty":-21.566646,"median":-13.832338,"eighty":-10.178399,"marketCap":6735058739},{"date":"2026-04-24","current":-33.568622,"twenty":-21.763823,"median":-13.900555,"eighty":-10.208356,"marketCap":6115368105},{"date":"2026-04-30","current":-33.100378,"twenty":-21.978395,"median":-13.921158,"eighty":-10.250713,"marketCap":6033829863},{"date":"2026-05-08","current":-31.214339,"twenty":-22.706211,"median":-13.994647,"eighty":-10.30018,"marketCap":5707676898},{"date":"2026-05-15","current":-29.131083,"twenty":-22.776319,"median":-14.017815,"eighty":-10.336399,"marketCap":5340754811},{"date":"2026-05-22","current":-27.81593,"twenty":-23.047102,"median":-14.048607,"eighty":-10.389647,"marketCap":5087986263},{"date":"2026-05-29","current":-27.541852,"twenty":-23.172279,"median":-14.1368,"eighty":-10.464957,"marketCap":5055370966},{"date":"2026-06-05","current":-25.017892,"twenty":-23.363875,"median":-14.19577,"eighty":-10.544198,"marketCap":4598756814},{"date":"2026-06-12","current":-23.303694,"twenty":-23.387069,"median":-14.29256,"eighty":-10.644994,"marketCap":4280757673},{"date":"2026-06-18","current":-21.659992,"twenty":-23.385252,"median":-14.360446,"eighty":-10.717921,"marketCap":3987220004},{"date":"2026-06-26","current":-19.35709,"twenty":-23.387069,"median":-14.42484,"eighty":-10.792723,"marketCap":3546913500},{"date":"2026-07-03","current":-22.633088,"twenty":-23.387069,"median":-14.528358,"eighty":-10.835308,"marketCap":4150296487},{"date":"2026-07-10","current":-22.571858,"twenty":-23.387069,"median":-14.594412,"eighty":-10.895206,"marketCap":4133988838},{"date":"2026-07-17","current":-24.887393,"twenty":-23.422297,"median":-14.645857,"eighty":-10.941531,"marketCap":4574295342},{"date":"2026-07-24","current":-23.950397,"twenty":-23.590541,"median":-14.676842,"eighty":-11.021709,"marketCap":4403065035},{"date":"2026-07-31","current":-22.399856,"twenty":-23.661546,"median":-14.734877,"eighty":-11.15174,"marketCap":4125835014},{"date":"2026-08-07","current":-23.394741,"twenty":-23.661546,"median":-14.760347,"eighty":-11.182792,"marketCap":4317449882},{"date":"2026-08-14","current":-23.475478,"twenty":-23.738529,"median":-14.797369,"eighty":-11.216408,"marketCap":4337834442},{"date":"2026-08-21","current":-23.269609,"twenty":-23.738529,"median":-14.83405,"eighty":-11.231051,"marketCap":4309296057},{"date":"2026-08-28","current":-23.330363,"twenty":-23.739485,"median":-14.83405,"eighty":-11.231051,"marketCap":4321526794},{"date":"2026-09-04","current":-29.87082,"twenty":-23.808592,"median":-14.83405,"eighty":-11.231051,"marketCap":4374526651},{"date":"2026-09-11","current":-29.635956,"twenty":-23.937318,"median":-14.83405,"eighty":-11.231051,"marketCap":4345988266},{"date":"2026-09-15","current":-29.69639,"twenty":-23.976138,"median":-14.83405,"eighty":-11.231051,"marketCap":4354142090}],"updateTime":1789523814887},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"01477\",pageSize:20,pageCount:3,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2665368530","title":"華泰製藥「救命藥」存致命缺陷，被踢出國家集採","url":"https://stock-news.laohu8.com/highlight/detail?id=2665368530","media":"市场资讯","labels":["productRelease","policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665368530?lang=zh_tw&edition=fundamental","pubTime":"2026-09-05 11:30","pubTimestamp":1788579000,"startTime":"0","endTime":"0","summary":"国家组织药品联合采购办公室随后发布公告，决定取消山东北大高科华泰制药有限公司盐酸胺碘酮注射液的国家集采中选资格，并将其列入“违规名单”，自2026年6月9日至2027年12月8日暂停该企业参与国家集采的申报资格，主供地区已启动供应企业替补程序。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/companyt/2026-09-05/doc-iniquimq3570598.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"productRelease,policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["01477","BK1574","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1127539777","title":"歐康維視生物-B2026年8月股份變動月報表：股本保持穩定","url":"https://stock-news.laohu8.com/highlight/detail?id=1127539777","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1127539777?lang=zh_tw&edition=fundamental","pubTime":"2026-09-04 22:06","pubTimestamp":1788530791,"startTime":"0","endTime":"0","summary":"欧康维视生物-B于2026年9月4日披露截至2026年8月31日止月份的证券变动月报表。公告显示，公司法定/注册股本维持在5,000,000,000股普通股，每股面值USD 0.00001，总额USD 50,000，与上月一致。截至2026年8月31日，公司已发行的普通股数量为815,382,414股，库藏股为20,949,500股，合计836,331,914股，与上月完全相同。在股权激励方面，2018年5月23日采纳的员工购股权计划下，报告期末尚有13,317,816份期权未行使。在2021年购股权计划下，因64,782份期权在8月失效，余下期末持有的期权为45,232,718份。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01477"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664241388","title":"中生製藥(01177.HK)GPC3 ADC臨床試驗申請獲FDA批准","url":"https://stock-news.laohu8.com/highlight/detail?id=2664241388","media":"阿斯达克财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664241388?lang=zh_tw&edition=fundamental","pubTime":"2026-09-04 09:24","pubTimestamp":1788485040,"startTime":"0","endTime":"0","summary":"中国生物制药(01177.HK) 公布，集团附属公司正大天晴自主研发的国家1类新药TQB6426“GPC3抗体药物偶联物(ADC)”已获得美国食品药品监督管理局(FDA)的新药临床试验(IND)批准，拟用于晚期恶性肿瘤。目前，全球尚无靶向GPC3的ADC药物获批上市，同类候选产品整体处于临床前及早期临床探索阶段。集团将加速TQB6426的I期临床试验，评估其在晚期恶性肿瘤患者中的安全性、耐受性、药代动力学特征及初步疗效，尽早为全球肝细胞癌及更多实体瘤患者提供新的治疗选择。(sl/a)(港股报价延迟最少十五分钟。沽空资料截至 2026-09-03 16:25。)AASTOCKS新闻","market":"other","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20220728114525438_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20220728114525438_s.jpg"],"rights":{"source":"aastocks_highlight","url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1542877/latest-news/AAFN","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1542877/latest-news/AAFN","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["BK1574","BK1515","BK1589","IE00BZ08YS42.EUR","IE00BZ08YR35.GBP","01477","01177","HK0000165453.HKD","BK1521","BK1191","IE00BZ08YT58.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664782740","title":"百奧賽圖與齊魯製藥達成全人納米抗體分子非排他授權合作，支持神經領域創新藥物開發","url":"https://stock-news.laohu8.com/highlight/detail?id=2664782740","media":"美通社","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664782740?lang=zh_tw&edition=fundamental","pubTime":"2026-09-03 14:23","pubTimestamp":1788416580,"startTime":"0","endTime":"0","summary":"北京2026年9月3日 /美通社/ -- 百奥赛图（北京）医药科技股份有限公司于2026年9月2日宣布，公司近期与齐鲁制药有限公司签署全人纳米抗体分子非排他授权合作协议。根据协议，百奥赛图将向齐鲁制药授权一款全人纳米抗体分子，用于支持其在神经领域创新药物项目中的研发探索。通过此次授权，齐鲁制药可结合其自身研发策略，对相关纳米抗体分子开展进一步研究和开发，后续项目的开发形式将根据项目特点和治疗需求灵活推进。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"prnasia","url":"http://wwwold.prnasia.com/story/archive/5039953_ZH39953_1","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://wwwold.prnasia.com/story/archive/5039953_ZH39953_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"prnasia","symbols":["01477","BK1161","BK1191","LNGR","BK0216","06978","MEDX","02315","688796","BK1574","IBBQ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664014829","title":"大行評級丨高盛：下調歌禮制藥目標價至13.86港元，維持「中性」評級","url":"https://stock-news.laohu8.com/highlight/detail?id=2664014829","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664014829?lang=zh_tw&edition=fundamental","pubTime":"2026-09-03 14:04","pubTimestamp":1788415446,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["01672","BK1574","01477","BK1515","BK1161","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664826093","title":"《大行》里昂：全球製藥供應鏈進入十年重整  首選Thermo Fisher(TMO.US)、藥明康德(02359.HK)等平台龍頭","url":"https://stock-news.laohu8.com/highlight/detail?id=2664826093","media":"阿斯达克财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664826093?lang=zh_tw&edition=fundamental","pubTime":"2026-09-03 13:15","pubTimestamp":1788412500,"startTime":"0","endTime":"0","summary":"里昂发表全球医疗健康行业展望报告指出，全球制药供应链正进入长达十年的重整。价值创造将愈来愈集中于具备规模、技术，以及全球在地布局的平台型龙头，该行认为Thermo Fisher、瑞士Lonza及中国药明康德分别体现美国、欧洲及中国的结构优势，为本轮行业重置的首选受惠者。个股方面，该行首次覆盖Thermo Fisher予“跑赢大市”评级，目标价748美元，看好其作为领先生命科学工具平台，对生物制药投资复苏及美国制造回流具最广曝光。","market":"fut","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20220419153917927_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20220419153917927_s.jpg"],"rights":{"source":"aastocks_highlight","url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1542763/latest-news/AAFN","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1542763/latest-news/AAFN","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["BK1583","LU1997244956.HKD","LU1934453819.USD","LU0348767384.USD","LU1303224171.USD","IE00BPRC5H50.USD","LU1046422090.SGD","LU2242644610.SGD","LU0348766576.USD","LU1251922891.USD","BK1576","BK1191","LU0611395673.USD","IE00B5MMRT66.SGD","LU2495084118.USD","LU1770034418.SGD","BK0216","LU0456842615.SGD","LU1808992512.USD","LU1997245177.USD","BK1574","LU0469268626.HKD","BK1141","LU0700851271.USD","LU0320764599.SGD","01477","LU1997245094.SGD","LU1979443071.USD","LU1969619763.USD","LU2125910500.SGD","LU2488822045.USD","LU0572944931.SGD","LU2045819591.USD","LU2328871848.SGD","603259","LU1719994722.HKD","LU0052750758.USD","IE00B543WZ88.USD","LU0327786744.USD","02359","LU0708995583.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1104328987","title":"歐康維視生物-B（01477）宣佈OT-211中國III期臨床試驗完成398名患者入組","url":"https://stock-news.laohu8.com/highlight/detail?id=1104328987","media":"公告速递","labels":["dataReport","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1104328987?lang=zh_tw&edition=fundamental","pubTime":"2026-09-02 20:16","pubTimestamp":1788351373,"startTime":"0","endTime":"0","summary":"欧康维视生物-B9月2日发布自愿性公告称，OT-211在中国开展的III期临床试验已顺利完成全部患者入组，累计入组人数为398人。2026年3月，OT-211在中国III期临床试验完成首例患者入组，此次全部入组完成标志着项目在国内临床开发进程的重要里程碑。OT-211曾于2025年5月28日获得FDA批准，用于治疗DED的体征及症状。公司同时提醒，OT-211能否最终成功开发并实现商业化仍存在不确定性。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01477"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664811365","title":"歐康維視生物-B(01477)：OT-211 III期臨床試驗完成患者入組","url":"https://stock-news.laohu8.com/highlight/detail?id=2664811365","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664811365?lang=zh_tw&edition=fundamental","pubTime":"2026-09-02 20:14","pubTimestamp":1788351299,"startTime":"0","endTime":"0","summary":"欧康维视生物-B公布，OT-211在中华人民共和国开展的III期临床试验已于近日完成合共398名患者的入组。2026年3月，OT-211于中国的III期临床试验完成首例患者入组，标志着 OT-211在中国的临床开发取得重要里程碑进展，并体现了本集团致力于为DED患者推进创新疗法。OT-211已于2025年5月28日获FDA批准用于治疗DED的体征及症状。本次OT-211的成功入组标志着公司与Alcon集团在新药开发领域也形成了强有力的合作与绑定，为后续新药共同探索与开发打下基础。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1491179.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1574","BMED","IBBJ","BK1191","PSYK","IBBQ","MDTX","01477"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664898526","title":"歌禮制藥-B早盤升逾8% ASC30用於長期體重管理的全球III期臨床項目完成首例受試者給藥","url":"https://stock-news.laohu8.com/highlight/detail?id=2664898526","media":"新浪港股","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664898526?lang=zh_tw&edition=fundamental","pubTime":"2026-09-02 10:13","pubTimestamp":1788315180,"startTime":"0","endTime":"0","summary":"模拟交易客户端歌礼制药-B早盘涨超8%，截至发稿，股价上涨8.07%，现报10.31港元，成交额926.46万港元。近日，歌礼制药-B发布公告，ASC30用于长期体重管理的全球III期临床项目已完成首例受试者给药。ASC30是一款歌礼专有的、正在临床研究中的每日一次口服小分子胰高血糖素样肽-1受体激动剂，开发用于长期体重管理和糖尿病治疗。公告称，歌礼制药-B预计将于2028年第三季度公布AURORA III期临床项目的顶线数据。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/marketalerts/2026-09-02/doc-iniqkzma1311603.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK1574","01477","01672","BK1191","BK1161","BK1515"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664260860","title":"港股異動 | 歌禮制藥-B(01672.HK)升逾5% ASC30用於長期體重管理的全球III期臨床項目完成首例受試者給藥","url":"https://stock-news.laohu8.com/highlight/detail?id=2664260860","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664260860?lang=zh_tw&edition=fundamental","pubTime":"2026-09-02 09:49","pubTimestamp":1788313757,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["01477","BK1191","BK1515","01672","BK1161","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664705860","title":"歌禮制藥－Ｂ(01672)股價上升5.031%，現價港幣$10.02","url":"https://stock-news.laohu8.com/highlight/detail?id=2664705860","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664705860?lang=zh_tw&edition=fundamental","pubTime":"2026-09-02 09:45","pubTimestamp":1788313500,"startTime":"0","endTime":"0","summary":"[上升股]歌礼制药－Ｂ(01672) 股价在上午09:45比前收市价上升5.031%，现股价为港币$10.02。至目前为止，今日最高价为$10.02，而最低价为$9.5。总成交量为25.5万股，总成交金额为港币$249.866万。","market":"hk","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20180416150419953_s.png","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20180416150419953_s.png"],"rights":{"source":"aastocks_highlight","url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAR260902625/aamm-all-category","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAR260902625/aamm-all-category","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["BK1574","01672","BK1161","01477","BK1191","BK1515"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1198144529","title":"歐康維視生物：地塞米松眼內懸濁液上市申請獲國家藥監局受理","url":"https://stock-news.laohu8.com/highlight/detail?id=1198144529","media":"投资观察","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1198144529?lang=zh_tw&edition=fundamental","pubTime":"2026-09-02 00:09","pubTimestamp":1788278991,"startTime":"0","endTime":"0","summary":"路透9月1日消息——欧康维视生物（股票代码：1477.HK）今日宣布，其地塞米松眼内悬浊液的新药上市申请，已正式获得中国国家药品监督管理局（NMPA）受理，该申请被归类为4类化学药品。此次受理标志着公司在眼科治疗领域的又一重要进展。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1191","BK1574","01477"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664850928","title":"諾華製藥（NVS）漲6% 在BTK抑制劑賽道迎來重要突破","url":"https://stock-news.laohu8.com/highlight/detail?id=2664850928","media":"金吾财讯","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664850928?lang=zh_tw&edition=fundamental","pubTime":"2026-09-01 23:18","pubTimestamp":1788275914,"startTime":"0","endTime":"0","summary":"金吾财讯 | 诺华制药 早盘股价扬升，最新涨6%，报161.2美元，成交额3.2亿美元。诺华周二公布，对比对照药物特立氟胺，瑞米布替尼可降低患者疾病复发率，减少脑部病灶数量，试验中未观察到肝脏相关安全风险。该药有望成为诺华重磅产品Kesimpta的后续迭代品种，同时印证BTK抑制剂在抑制异常免疫反应方面的治疗潜力。诺华计划向全球监管机构提交瑞米布替尼治疗多发性硬化症的上市申请，完整临床数据将于今年晚些时候在多伦多医学会议对外披露。","market":"sh","thumbnail":"https://static.szfiu.com/news/20250107/YmFmZjgzNDhkMjgxZmE5MWVmYzk4MzgzNTg2ODExODg1NTU0MA==.png","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250107/YmFmZjgzNDhkMjgxZmE5MWVmYzk4MzgzNTg2ODExODg1NTU0MA==.png"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"305587","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0070302665.USD","LU0320765489.SGD","LU0211331839.USD","IE0009355771.USD","BK1191","IE00B4R5TH58.HKD","IE00B2B36J28.USD","BK1574","NVS","LU0208291251.USD","BK4585","BK4532","IE00BJT1NW94.SGD","BK4588","PPH","01477","IE0002141913.USD","BK4007","BK4578","IE00BJJMRZ35.SGD","MEDX","IE00BFTCPJ56.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664524478","title":"諾華製藥(NVS)股票9月1日盤中上漲6.54%：真相來了","url":"https://stock-news.laohu8.com/highlight/detail?id=2664524478","media":"TradingKey中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664524478?lang=zh_tw&edition=fundamental","pubTime":"2026-09-01 22:16","pubTimestamp":1788272176,"startTime":"0","endTime":"0","summary":"• Remibrutinib 在三期多发性硬化症试验中取得成功，展现出临床优效性。\n• 在三名患者死亡后，诺华暂停了八项早期 CAR-T 试验。\n• 该公司报告年收入为 563.3 亿美元，净利润为 139.8 亿美元。","market":"hk","thumbnail":"https://resource.tradingkey.com/uploads/20251024/Novartis-369e71de347f479fa3f300f9d7904bc5.jpg","type":0,"news_type":0,"thumbnails":["https://resource.tradingkey.com/uploads/20251024/Novartis-369e71de347f479fa3f300f9d7904bc5.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tradingkey.com/zh-hans/news/market-movers/262144173-market-movers-nvs-20260901","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0320765489.SGD","BK1574","IE00BJJMRZ35.SGD","NVS","01477","BK4007","BK4588","LU0211331839.USD","IE00BFTCPJ56.SGD","MEDX","PPH","BK4578","BK1191","LU0070302665.USD","BK4532","IE0009355771.USD","IE0002141913.USD","BK4585","IE00B2B36J28.USD","IE00B4R5TH58.HKD","IE00BJT1NW94.SGD","LU0208291251.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1100575152","title":"歐康維視生物-B：地塞米松眼用混懸注射液境內生產註冊申請獲國家藥監局受理","url":"https://stock-news.laohu8.com/highlight/detail?id=1100575152","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1100575152?lang=zh_tw&edition=fundamental","pubTime":"2026-09-01 20:01","pubTimestamp":1788264115,"startTime":"0","endTime":"0","summary":"2026年9月1日，欧康维视生物-B发布自愿性公告称，其核心药物OT-502的境内生产品种——地塞米松眼用混悬注射液的药品注册申请已获国家药品监督管理局药品审评中心按化药4类受理，并已申请纳入药品审评中心优先审评品种名单且完成公示程序。视姝是一种单剂量缓释的地塞米松眼用混悬液，用于治疗眼科术后炎症。若本次注册申请获批，公司将通过OT-502技术转移在中国内地生产地塞米松眼用混悬注射液，以取代现有的海外生产及进口模式。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01477"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664856154","title":"歐康維視生物-B(01477.HK)：境內生產的地塞米松眼用混懸注射液藥品註冊申請獲受理","url":"https://stock-news.laohu8.com/highlight/detail?id=2664856154","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664856154?lang=zh_tw&edition=fundamental","pubTime":"2026-09-01 19:59","pubTimestamp":1788263997,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK1574","BK1191","01477"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1147045285","title":"歐康維視生物-B：國產地塞米松眼內懸濁液藥品註冊申請獲受理","url":"https://stock-news.laohu8.com/highlight/detail?id=1147045285","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1147045285?lang=zh_tw&edition=fundamental","pubTime":"2026-09-01 19:59","pubTimestamp":1788263953,"startTime":"0","endTime":"0","summary":"欧康维视生物-B近日宣布，其自主研发的地塞米松眼内悬浊液药品注册申请已正式获得受理。欧康维视生物作为一家专注于眼科领域的创新药企，持续推进其产品管线，此次申请受理是其研发进程中的重要里程碑。欧康维视生物表示，将继续与监管机构保持密切沟通，推动该产品的审评进程，并致力于加速其他在研产品的开发，以满足眼科领域未被满足的医疗需求。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1574","BK1191","01477"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1192737919","title":"歐康維視生物-B：地塞米松眼內懸濁液獲藥監局受理，列為化藥四類","url":"https://stock-news.laohu8.com/highlight/detail?id=1192737919","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1192737919?lang=zh_tw&edition=fundamental","pubTime":"2026-09-01 19:59","pubTimestamp":1788263950,"startTime":"0","endTime":"0","summary":"欧康维视生物-B（01477.HK）宣布，其地塞米松眼内悬浊液的上市申请已获国家药品监督管理局（NMPA）正式受理。该药品被归类为化学药品第4类，这一进展标志着公司在眼科治疗领域又迈出了重要一步。此次受理的申请，不仅凸显了该产品在中国市场的监管审批进程中的关键节点，也为公司未来在该细分市场的布局增添了新的砝码。随着监管流程的推进，该药物有望为相关眼科疾病患者提供新的治疗选择。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1191","BK1574","01477"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664837323","title":"南新制藥股民索賠案獲受理","url":"https://stock-news.laohu8.com/highlight/detail?id=2664837323","media":"市场资讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664837323?lang=zh_tw&edition=fundamental","pubTime":"2026-09-01 17:17","pubTimestamp":1788254220,"startTime":"0","endTime":"0","summary":"原告代理人之一、浙江裕丰律师事务所厉健律师表示，根据处罚决定，南新制药涉嫌证券虚假陈述，我们代理的部分股民索赔案已获上海金融法院正式受理。湖南证监局决定：对南新制药给予警告，并处以500万元罚款；对相关责任人员给予警告，并各处以罚款。厉健律师表示，根据司法解释，暂定：在2024年3月26日至2025年9月30日期间买入该股票，并在2025年9月30日收盘还持有南新制药股票的受损股民，可索赔。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/observe/2026-09-01/doc-iniqihzu4835859.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK1574","BK1191","01477"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664831619","title":"諾華製藥(NVS.US)神經免疫管線「悲喜交加」：患者死亡致CAR-T臨床試驗暫停 MS口服藥後期試驗告捷","url":"https://stock-news.laohu8.com/highlight/detail?id=2664831619","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664831619?lang=zh_tw&edition=fundamental","pubTime":"2026-09-01 15:40","pubTimestamp":1788248407,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，诺华制药在神经与自身免疫领域迎来“冰火两重天”：公司因三名患者死亡紧急叫停八项CAR-T疗法临床试验;不过，其多发性硬化症口服药remibrutinib在后期临床试验中取得积极结果。CAR-T试验紧急暂停诺华制药在8月底暂停了八项针对自身免疫和神经系统疾病的实验性疗法临床试验，此前有三名患者死亡。诺华制药发言人表示，公司正在“对所观察到的安全事件进行全面审查”，并将这种致命免疫反应描述为CAR-T疗法中已知的安全风险。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1490282.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["PSYK","BK4578","MDTX","BK1191","MEDX","BMED","01477","IE00B2B36J28.USD","BK1574","IE00BFTCPJ56.SGD","BK4532","BK4588","LU0320765489.SGD","LU0070302665.USD","IE00B4R5TH58.HKD","BK4585","LU0208291251.USD","IE00BJT1NW94.SGD","IE0002141913.USD","PPH","IE0009355771.USD","IE00BJJMRZ35.SGD","NVS","LU0211331839.USD","BK4007","IBBQ","IBBJ"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":3,"totalSize":200,"code":"91000000","status":"200"}]}}